XM n’offre pas ses services aux résidents des États-Unis d’Amérique.
G
G

Groupon


Actualités

Tempus AI stretches rally as co and SoftBank launch AI healthcare JV

BUZZ-Tempus AI stretches rally as co and SoftBank launch AI healthcare JV ** Shares of genetics testing firm Tempus AI TEM.O , backed by SoftBank 9984.T , up ~7% early Thurs, adding to ~10% gain in prior session ** SoftBank has launched joint venture with Tempus aiming to analyze personal medical data with artificial intelligence to come up with treatment recommendations, CEO Masayoshi Son told a briefing in Tokyo on Thurs ** The cos expected to each put $93 mln into the JV, which is anticipated
G

SoftBank-backed Tempus AI sinks to new post-IPO lows

BUZZ-SoftBank-backed Tempus AI sinks to new post-IPO lows ** Shares of Tempus AI TEM.O , genetics testing firm backed by SoftBank 9984.T , down 2.7% at $24.63 on Tues and now off ~33% from IPO price ** Stock drops as much as 9.6% to $22.89 on the session ** TEM shares on track to fall for fifth time in past six days since closing up nearly 9% at $40.25 in their Jun 14 debut ** Tempus, founded in 2015 and has yet to turn a profit, raised ~$411 mln by selling 11.1 mln shares at $37 , top end of ma
G

SoftBank-backed Tempus AI extends slump after strong listing

BUZZ-SoftBank-backed Tempus AI extends slump after strong listing Updates ** Shares of SoftBank 9984.T -backed Tempus AI TEM.O tumble as much as ~ 21 % to slump for the third straight session ** The genetics testing firm, led by Groupon GRPN.O co-founder Eric Lefkofsky, closed up 8.8% at $40.25 on its market debut on Friday, June 14 ** Shares fell 9.4% on Monday and 16.9% on Tuesday ** Tempus, which was founded in 2015 and is yet to post a profit, raised $410.7 mln by selling 11.1 mln shares at
G

SoftBank-backed Tempus AI extends slump after strong listing

BUZZ-SoftBank-backed Tempus AI extends slump after strong listing ** Shares of SoftBank 9984.T -backed Tempus AI TEM.O tumble as much as 20% to slump for the third straight session ** The genetics testing firm, led by Groupon GRPN.O co-founder Eric Lefkofsky, closed up 8.8% at $40.25 on its market debut on Friday, June 14 ** Shares fell 9.4% on Mon
G

SoftBank-backed Tempus AI tumbles well below IPO price

BUZZ-SoftBank-backed Tempus AI tumbles well below IPO price ** Shares of Tempus AI TEM.O , genetics testing firm backed by SoftBank 9984.T , down 16% at $30.65 on Tues in their third day of trading ** TEM, which shed ~9% on Mon, tumbles as low as $30.31 on the session ** Stock now >17% below $37 IPO price set late Thurs after co raised ~$411 mln by selling 11.1 mln shares ** TEM traded as high as $43.88 in debut on Fri before closing at $40.25 ** Co led by Groupon GRPN.O co-founder Eric Lefkofsk
G

IBM settles lawsuit against Rakuten over e-commerce patents

IBM settles lawsuit against Rakuten over e-commerce patents By Blake Brittain June 17 (Reuters) - International Business Machines Corp IBM.N has settled a lawsuit accusing Japan's Rakuten 4755.T of infringing IBM patents related to e-commerce technology, Delaware federal court records showed on Monday. U.S. District Judge Gregory Williams said in an oral order that he was "pleased to hear that the parties have reached an agreement to settle this case," according to an entry on the court's docket
G

Tempus AI prices US IPO at over $6 bln valuation

UPDATE 1-Tempus AI prices US IPO at over $6 bln valuation Updates with details in paragraph 2,3 and background in paragraph 4,5 June 13 (Reuters) - SoftBank Group-backed 9984.T Tempus AI set the pricing of its U.S. initial public offering at $37 per share on Thursday, aiming to raise $410.7 million. The genetics-testing company priced its IPO at the higher end of is targeted range of $35 to $37, valuing the firm at about $6.10 billion, based on the outstanding shares listed in its filing with th
G

SoftBank-backed Tempus AI seeks up to $6.1 bln valuation in US IPO

UPDATE 2-SoftBank-backed Tempus AI seeks up to $6.1 bln valuation in US IPO Adds background and details on competitors, customers and funding in paragraphs 4-10 June 5 (Reuters) - Tempus AI, backed by Japanese tech investment firm SoftBank Group 9984.T , is targeting a valuation of up to $6.10 billion for its U.S. initial public offering, nearly three years after the genetics-testing company laid the ground for its listing.
A
G
G
R
V

Precision-medicine IPO deserves Groupon discount

BREAKINGVIEWS-Precision-medicine IPO deserves Groupon discount The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Robert Cyran NEW YORK, May 31 (Reuters Breakingviews) - Personalized cancer treatments developed using genetic data crunched by artificial intelligence under the watch of a board that includes a Nobel laureate is the sort of business that should be an easy sell in today’s stock market.
G

U.S. STOCKS H&R Block, McDonald, Groupon

BUZZ-U.S. STOCKS ON THE MOVE-H&R Block, McDonald, Groupon Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock indexes were mixed on Friday, but looked on track for weekly gains ahead of key inflation readings next week that could provide more clues on how soon the Federal Reserve will start cutting interest rates.
A
D
G
H
U
U
C
A
B
M

Groupon shares surge 30% after qtrly report exceeds expectations

BUZZ-Groupon shares surge 30% after qtrly report exceeds expectations ** Shares of Groupon GRPN.O surge >30% on Fri, on track for biggest daily pct gain since Mar 2021, after e-commerce marketplace late Thurs reported Q1 rev above LSEG consensus expectations ** Stock last up 31% at $13.76 ** Rev in qtr of $123.1 mln, up 1% yr/yr, topped avg analyst
G

Groupon Q1 Revenue USD 123.1 Million

BRIEF-Groupon Q1 Revenue USD 123.1 Million May 09 (Reuters) - Groupon Q1 adjusted EBITDA USD 19.5 million. Q1 gross profit USD 110.6 million Q1 billings USD 381.1 million Q1 net income USD -11.5 million
G

Groupon Inc <GRPN.OQ> expected to post earnings of 5 cents a share - Earnings Preview

Groupon Inc expected to post earnings of 5 cents a share - Earnings Preview Groupon Inc GRPN.OQ GRPN.O is expected to show a fall in quarterly revenue when it reports results on May 9 for the period ending March 31 2024 The Chicago Illinois-based company is expected to report a 3.4% decrease in revenue to $117.45 million from $121.61 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.The company's guidance on March 15 2024, for the period ended March 31, was
G

U.S. Berkshire Hathaway, Parker-Hannifin, Quaker Houghton

U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Parker-Hannifin, Quaker Houghton May 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Berkshire Hathaway, Parker-Hannifin and Quaker Houghton, on Monday. HIGHLIGHTS * Berkshire Hathaway BRKa.N : KBW raises target price to $660,000 from $645,000 * Essex Property Trust Inc ESS.N : Piper Sandler raises target price to $315 from $291 * Parker-Hannifin Corp PH.N : Jefferies cuts
A
C
E
G
E
C
C



Conditions

Actifs populaires

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques